Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S K Takemoto

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Clinical Transplants|August 22, 2001
Maintenance immunosuppressionS K Takemoto
Clinical Transplants|September 6, 2002
Maintenance immunosuppressionS K Takemoto
Clinical Transplants|January 1, 1996
HLA amino acid residue matchingS K Takemoto
Clinical Transplants|January 1, 1997
Class I peptides involved in the indirect pathway of allorecognitionS K Takemoto
Transplantation Proceedings|November 13, 2003
Controlling treatment allocation bias in a registry analysis when comparing calcineurin inhibitorsS Bunnapradist, S K Takemoto
Transplantation Proceedings|April 26, 2005
Multivariate analysis of antibody induction therapy and their associated outcomes in deceased donor transplantsS Bunnapradist, S K Takemoto
Current Opinion in Nephrology and Hypertension|May 1, 1997
Evaluation of the transplant recipient and donor: molecular approach to tissue typing, flow cytometry and alternative approaches to distributing organsS K Takemoto, P I Terasaki
Lancet (London, England)|June 24, 2000
Improving HLA matching for kidney transplantation by use of CREGsR M McKenna, S K Takemoto
Transplantation Proceedings|February 1, 1997
Benefits of HLA-CREG matching for sensitized recipients as illustrated in kidney regraftsS K Takemoto, J M Cecka, P I Terasaki
Transplantation Proceedings|April 26, 2005
Multivariate analysis of the effectiveness of using antibody induction therapy according to the degree of HLA mismatchesS Bunnapradist, A Hong, B Lee, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Clinical Transplants|August 22, 2001
Maintenance immunosuppressionS K Takemoto
Clinical Transplants|September 6, 2002
Maintenance immunosuppressionS K Takemoto
Clinical Transplants|January 1, 1996
HLA amino acid residue matchingS K Takemoto
Clinical Transplants|January 1, 1997
Class I peptides involved in the indirect pathway of allorecognitionS K Takemoto
Transplantation Proceedings|November 13, 2003
Controlling treatment allocation bias in a registry analysis when comparing calcineurin inhibitorsS Bunnapradist, S K Takemoto
Transplantation Proceedings|April 26, 2005
Multivariate analysis of antibody induction therapy and their associated outcomes in deceased donor transplantsS Bunnapradist, S K Takemoto
Current Opinion in Nephrology and Hypertension|May 1, 1997
Evaluation of the transplant recipient and donor: molecular approach to tissue typing, flow cytometry and alternative approaches to distributing organsS K Takemoto, P I Terasaki
Lancet (London, England)|June 24, 2000
Improving HLA matching for kidney transplantation by use of CREGsR M McKenna, S K Takemoto
Transplantation Proceedings|February 1, 1997
Benefits of HLA-CREG matching for sensitized recipients as illustrated in kidney regraftsS K Takemoto, J M Cecka, P I Terasaki
Transplantation Proceedings|April 26, 2005
Multivariate analysis of the effectiveness of using antibody induction therapy according to the degree of HLA mismatchesS Bunnapradist, A Hong, B Lee, et al.
Pageof 3